Recap: Larimar Therapeutics Q4 Earnings

Benzinga ·  Mar 14 17:15

Larimar Therapeutics (NASDAQ:LRMR) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.


Larimar Therapeutics missed estimated earnings by -20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 14.000000000000002% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Larimar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment